✦ LIBER ✦

Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient

✍ Scribed by László Lujber; Imre Gerlinger; Ádám Kuncz; József Pytel

Book ID: 117090356
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 250 KB
Volume: 64
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(03)00111-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination Antifungal Therapy for Invas

Combination Antifungal Therapy for Invasive Aspergillosis Infection in Liver Transplant Recipients: Report of Two Patients

✍ Dr. Iman E. Bajjoka; Dr. Elaine M. Bailey; Dr. Jose A. Vazquez; Dr. Marwan S. Ab 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Clinical features of invasive bronchial-

Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study

✍ Hangyong He; Lin Ding; Fang Li; Qingyuan Zhan 📂 Article 📅 2011 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 865 KB

38: Comparison of Voriconazole Versus a

38: Comparison of Voriconazole Versus a Combination of Voriconazole and Caspofungin as Primary Therapy for Suspected Invasive Aspergillosis in Lung Transplant Recipients

✍ C. Fegbeutel; F. Mattner; H. Weissbrodt; J. Gottlieb; M. Strueber; T. Welte; A. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Case report on the clinical results of a

Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients

✍ Moviglia, G A; Varela, G; Brizuela, J A; Moviglia Brandolino, M T; Farina, P; Et 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Liposomal amphotericin B in combination

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies : A randomized pilot study (Combistrat trial)

✍ Denis Caillot; Anne Thiébaut; Raoul Herbrecht; Stéphane de Botton; Arnaud Pigneu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a

Fatal breakthrough Scedosporium apiosper

Fatal breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis in a patient following high-risk allogeneic BMT

✍ Amar Safdar; E.B. Papadopoulous; J.W. Young 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 290 KB